(600976)"Jianmin Pharmaceutical Group Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 600976 · · 12 pages · Chinese
Jianmin Pharmaceutical Group Co Ltd. on 6ix
Earlier from Jianmin Pharmaceutical
- (600976)"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
- Announcement on Approval for Marketing of Crisaborole Ointment
- Semi-annual Report for 2026
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Inclusion of the Company's Products in the "National Essential Medicines List"
Follow Jianmin Pharmaceutical into a list and get an email when it puts out news.
Follow Jianmin Pharmaceutical